Wall Street Deal Making Faces Greater Scrutiny, Delays Under FTC’s Lina Khan
LIPA News and Updates



More than 200 organizations advocate passage of Pharmacy Benefit Manager Transparency Act


Healthcare Policy Expert: FTC Could Put Insurers' Drug Middlemen On A Diet

INDEPENDENT PHARMACIES BREAK THROUGH ON PBMS

CMS insurer price transparency rule has taken effect. Signs are good for compliance


The FTC inquiry into PBMs is a chance for accountability

Fears ease on new pharmacy deserts in Ohio: 'The state is going to save a lot of money'


Expert: ‘Vaccination Is a Team Sport,’ Pharmacists Are Key Players


Legal experts expect 'more scrutiny' of Medicare prior authorization from feds


NCPA Announces Support for Bipartisan PBM Transparency Bill

AMA: Insurers not sticking to prior authorizations deal from 2018


Senate Commerce Committee Issues Testimony From David A. Balto Law Offices Antitrust Attorney


Federal Litigation Update And Proposed Rule On Pharmacy Benefit Managers


Minnesota seeking $1.25M fine against CVS Caremark over alleged unlawful PBM practices


Asking the wrong questions

UnitedHealth Inflated Drug Costs, Louisiana Attorney General Alleges in Suit


What CVS, Cigna and other PBMs are doing in drug pricing is neither sustainable nor ethical


KPhA: Legislative Success!

The biggest PBMs are handling more and more of the country’s drug price negotiations

Survey Shows Concern over Pharmacy Benefit Manager Practices